These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 23745671)
1. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases. Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581 [TBL] [Abstract][Full Text] [Related]
3. Treatment for microcarcinoma of the thyroid--clinical experience. Küçük NO; Tari P; Tokmak E; Aras G Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573 [TBL] [Abstract][Full Text] [Related]
4. Prognosis and growth activity depend on patient age in clinical and subclinical papillary thyroid carcinoma. Ito Y; Miyauchi A; Kobayashi K; Miya A Endocr J; 2014; 61(3):205-13. PubMed ID: 24212880 [TBL] [Abstract][Full Text] [Related]
5. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience [corrected]. Al-Qahtani KH; Al Asiri M; Tunio MA; Aljohani NJ; Bayoumi Y; Fatani H; AlHadab A J Otolaryngol Head Neck Surg; 2015 Dec; 44():51. PubMed ID: 26621255 [TBL] [Abstract][Full Text] [Related]
9. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study. de Castro TP; Waissmann W; Simões TC; de Mello RC; Carvalho DP Clin Endocrinol (Oxf); 2016 Sep; 85(3):466-74. PubMed ID: 26834009 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. Pisanu A; Reccia I; Nardello O; Uccheddu A World J Surg; 2009 Mar; 33(3):460-8. PubMed ID: 19123022 [TBL] [Abstract][Full Text] [Related]
11. Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance. Londero SC; Krogdahl A; Bastholt L; Overgaard J; Trolle W; Pedersen HB; Bentzen J; Schytte S; Christiansen P; Godballe C; Thyroid; 2013 Sep; 23(9):1159-64. PubMed ID: 23427917 [TBL] [Abstract][Full Text] [Related]
12. Thyroglossal Duct Cyst Carcinomas: A Clinicopathologic Series of 22 Cases with Staging Recommendations. Thompson LDR; Herrera HB; Lau SK Head Neck Pathol; 2017 Jun; 11(2):175-185. PubMed ID: 27704385 [TBL] [Abstract][Full Text] [Related]
13. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452 [TBL] [Abstract][Full Text] [Related]
14. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506 [TBL] [Abstract][Full Text] [Related]
15. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196 [TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM; Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442 [TBL] [Abstract][Full Text] [Related]
17. Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence. Chu KP; Baker S; Zenke J; Morad A; Ghosh S; Morrish DW; McEwan AJBS; Williams DC; Severin D; McMullen TPW Thyroid; 2018 Jul; 28(7):902-912. PubMed ID: 29742993 [TBL] [Abstract][Full Text] [Related]
18. Management and outcome of recurrent well-differentiated thyroid carcinoma. Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757 [TBL] [Abstract][Full Text] [Related]
19. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery. Oda H; Miyauchi A; Ito Y; Yoshioka K; Nakayama A; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A Thyroid; 2016 Jan; 26(1):150-5. PubMed ID: 26426735 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer. Wu MH; Shen WT; Gosnell J; Duh QY Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]